Microbio Co Ltd (4128) - Total Assets
Based on the latest financial reports, Microbio Co Ltd (4128) holds total assets worth NT$12.03 Billion TWD (≈ $378.91 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Microbio Co Ltd - Total Assets Trend (2006–2025)
This chart illustrates how Microbio Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see Microbio Co Ltd (4128) market capitalisation for the company's overall valuation and market capitalisation.
Microbio Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Microbio Co Ltd's total assets of NT$12.03 Billion consist of 27.6% current assets and 72.4% non-current assets. Review 4128 liabilities breakdown to assess the company's total debt and financial obligations.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 5.8% |
| Accounts Receivable | NT$41.54 Million | 0.3% |
| Inventory | NT$260.99 Million | 2.1% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$110.64 Million | 0.9% |
| Goodwill | NT$39.41 Million | 0.3% |
Asset Composition Trend (2006–2025)
This chart illustrates how Microbio Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Microbio Co Ltd stock quote for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Microbio Co Ltd's current assets represent 27.6% of total assets in 2025, a decrease from 54.3% in 2006.
- Cash Position: Cash and equivalents constituted 5.8% of total assets in 2025, down from 29.6% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 6.0% in 2006.
- Asset Diversification: The largest asset category is inventory at 2.1% of total assets.
Microbio Co Ltd Competitors by Total Assets
Key competitors of Microbio Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Nestle India Limited
NSE:NESTLEIND
|
India | Rs131.82 Billion |
|
Grupo Bimbo S.A.B. de C.V
MX:BIMBOA
|
Mexico | MX$414.57 Billion |
|
Guangdong Haid Group Co Ltd
SHE:002311
|
China | CN¥55.29 Billion |
|
Maple Leaf Foods Inc.
TO:MFI
|
Canada | CA$4.45 Billion |
|
Greencore Group plc
F:GCG
|
Germany | €1.27 Billion |
|
JiangXi Tianxin Pharm Co Ltd
SHG:603235
|
China | CN¥6.25 Billion |
|
Bright Dairy & Food Co Ltd
SHG:600597
|
China | CN¥21.53 Billion |
|
Beijing Sanyuan Foods Co Ltd
SHG:600429
|
China | CN¥8.86 Billion |
Microbio Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.76 | 6.50 | 9.85 |
| Quick Ratio | 5.32 | 6.05 | 9.47 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$2.75 Billion | NT$2.57 Billion | NT$4.11 Billion |
Microbio Co Ltd - Advanced Valuation Insights
This section examines the relationship between Microbio Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.00 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | -11.4% |
| Total Assets | NT$12.33 Billion |
| Market Capitalization | $271.47 Million USD |
Valuation Analysis
Below Book Valuation: The market values Microbio Co Ltd's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Microbio Co Ltd's assets decreased by 11.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Microbio Co Ltd (2006–2025)
The table below shows the annual total assets of Microbio Co Ltd from 2006 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | NT$12.33 Billion ≈ $388.58 Million |
-11.44% |
| 2024-12-31 | NT$13.93 Billion ≈ $438.78 Million |
-5.48% |
| 2023-12-31 | NT$14.74 Billion ≈ $464.24 Million |
-2.36% |
| 2022-12-31 | NT$15.09 Billion ≈ $475.44 Million |
+0.49% |
| 2021-12-31 | NT$15.02 Billion ≈ $473.11 Million |
+7.84% |
| 2020-12-31 | NT$13.93 Billion ≈ $438.73 Million |
+38.54% |
| 2019-12-31 | NT$10.05 Billion ≈ $316.68 Million |
-1.77% |
| 2018-12-31 | NT$10.23 Billion ≈ $322.40 Million |
+11.71% |
| 2017-12-31 | NT$9.16 Billion ≈ $288.60 Million |
-1.04% |
| 2016-12-31 | NT$9.26 Billion ≈ $291.64 Million |
-5.86% |
| 2015-12-31 | NT$9.83 Billion ≈ $309.79 Million |
+0.90% |
| 2014-12-31 | NT$9.75 Billion ≈ $307.03 Million |
+2.16% |
| 2013-12-31 | NT$9.54 Billion ≈ $300.53 Million |
+31.37% |
| 2012-12-31 | NT$7.26 Billion ≈ $228.77 Million |
+9.27% |
| 2011-12-31 | NT$6.65 Billion ≈ $209.36 Million |
+20.10% |
| 2010-12-31 | NT$5.53 Billion ≈ $174.33 Million |
-6.18% |
| 2009-12-31 | NT$5.90 Billion ≈ $185.82 Million |
+160.04% |
| 2008-12-31 | NT$2.27 Billion ≈ $71.46 Million |
+30.51% |
| 2007-12-31 | NT$1.74 Billion ≈ $54.75 Million |
+116.92% |
| 2006-12-31 | NT$801.18 Million ≈ $25.24 Million |
-- |
About Microbio Co Ltd
Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and health foods in Taiwan. It provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia in women before menopause and relieved dysmenorrhea. The company is also involved in the sale of organic food and beverages; provision of te… Read more